Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.
Shahab AbtahiJohanna H M DriessenAndrea Michelle BurdenPatrick C SouvereinJoop P van den BerghTjeerd P van StaaAnnelies BoonenFrank de VriesPublished in: Annals of the rheumatic diseases (2020)
There was an interaction in the risk of osteoporotic fractures with concomitant use of oral GCs and PPIs. Fracture risk assessment could be considered when a patient with RA is co-prescribed oral GCs and PPIs.